Clinical trial on 5-AZA-2′-deoxycytidine in patients with acute leukemia
- 1 January 1985
- journal article
- clinical trial
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 30 (3) , 277-286
- https://doi.org/10.1016/0163-7258(85)90052-x
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Effects of 5-Aza-2′-deoxycytidine on survival and cell cycle progression of L1210 leukemia cellsLeukemia Research, 1986
- Sample preparation for the determination of 5-aza-2′-deoxycytidine in plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Effects of 5-azacytidine and its 2′-deoxyderivative on cell differentiation and DNA methylationPharmacology & Therapeutics, 1985
- High-dose cytosine arabinoside therapy for refractory leukemiaBlood, 1983
- Kinetics of deamination of 5-aza-2'-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinosideBiochemical Pharmacology, 1983
- Adult acute leukemia studies utilizing cytarabine: Early southwest oncology group trialsMedical and Pediatric Oncology, 1982
- Effect of schedule and combinations on clinical effectiveness of Ara-C in adult acute leukemiaMedical and Pediatric Oncology, 1982
- High-performance Liquid Chromatographic Analysis of Chemical Stability of 5-aza-2′-DeoxycytidineJournal of Pharmaceutical Sciences, 1981
- Cellular differentiation, cytidine analogs and DNA methylationPublished by Elsevier ,1980
- Cytarabine for acute leukemia in adults. Effect of schedule on therapeutic responseArchives of internal medicine (1960), 1974